| Literature DB >> 33053354 |
Tomoaki Inazumi1, Kiyotaka Yamada2, Naritoshi Shirata3, Hiroyasu Sato4, Yoshitaka Taketomi4, Kazunori Morita5, Hirofumi Hohjoh1, Soken Tsuchiya1, Kentaro Oniki5, Takehisa Watanabe6, Yutaka Sasaki6, Yuichi Oike7, Yasuhiro Ogata8, Junji Saruwatari5, Makoto Murakami9, Yukihiko Sugimoto10.
Abstract
Lipolysis, the breakdown of triglyceride storage in white adipose tissue, supplies fatty acids to other tissues as a fuel under fasting conditions. In morbid obesity, fibrosis limits adipocyte expandability, resulting in enforced lipolysis, ectopic fat distribution, and ultimately insulin resistance. Although basal levels of lipolysis persist even after feeding, the regulatory mechanisms of basal lipolysis remain unclear. Here, we show the important role of adipocyte prostaglandin (PG) E2-EP4 receptor signaling in controlling basal lipolysis, fat distribution, and collagen deposition during feeding-fasting cycles. The PGE2-synthesis pathway in adipocytes, which is coupled with lipolysis, is activated by insulin during feeding. By regulating the lipolytic key players, the PGE2-EP4 pathway sustains basal lipolysis as a negative feedback loop of insulin action, and perturbation of this process leads to "metabolically healthy obesity." The potential role of the human EP4 receptor in lipid regulation was also suggested through genotype-phenotype association analyses.Entities:
Keywords: EP4 receptor; adipocyte; aspirin-like drugs; collagen VI; free fatty acid; lipolysis; metabolically healthy obesity; nonalcoholic fatty liver disease; prostaglandin E(2); single nucleotide polymorphism
Year: 2020 PMID: 33053354 DOI: 10.1016/j.celrep.2020.108265
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423